Sean Singer

Sean Singer practices at Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham.

Sean Singer's NPI, 1528695772, was assigned on March 26, 2020. Sean Singer graduated from Harvard Medical School in 2020. Sean Singer holds Massachusetts license 1019736.

Sean Singer's primary practice is Brigham and Women's Hospital, at 75 Francis Street, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.

Sean Singer's primary practice is Brigham and Women's Hospital in Boston, Massachusetts, part of Mass General Brigham. Sean Singer is also affiliated with Dana-Farber Cancer Institute. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Sean Singer to 4 more group practices and clinics, 3 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sean Singer practices, 7 sites in all. Vendor and product names are available with a free account.

Dermatology is Sean Singer's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Sean Singer is licensed in Massachusetts.

CMS data shows 423 Medicare services from Sean Singer across 8 procedure codes in 2024, for 183 Medicare patients. Medicare paid $19,790 for them.

CMS counts 183 Medicare patients who saw Sean Singer in 2024. The largest group is 65 to 74, with 83 patients. 70% of them have high cholesterol, and 63% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sean Singer's median patient age at 72, with 48% women.

In 2024, Sean Singer wrote 261 Medicare Part D claims for 134 patients. 91% of them were for generic drugs. CMS names the drug for 132 of them, across 5 drugs with 11 or more claims each, at $5,909 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.

Sean Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sean Singer as offering telehealth. CMS counts 636 procedures of removal of skin lesions by Sean Singer, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 26 papers to Sean Singer, published from 2018 to 2020. 2020 was the busiest year, with 9. The most frequent topics are Skin Neoplasms, Gender Identity and Immune Checkpoint Inhibitors. Sean Singer has published most often in JAMA Dermatol. Sean Singer's most frequent co-authors are Arash Mostaghimi, MD, MPA, MPH, Elizabeth Tkachenko, MD and Ai-Tram Ngoc Bui, MD.

CMS Open Payments shows 2 general payments to Sean Singer from 2 drug and device companies in 2025. Education make up the largest share, 56% of the total. Janssen Pharmaceuticals, Inc paid the most, $100.

Sean Singer graduated from Harvard Medical School in 2020.